ClearCam Inc., a medical device spinout company founded by Cockrell School of Engineering associate professor Chris Rylander based on research from his lab, recently announced the closing of $2.6 million in seed round funding.
Founded in 2018, ClearCam invented and is manufacturing the Kelling Device (Kelling) — a simple mechanical and efficient disposable in-vivo laparoscopic lens cleaner that eliminates the need for clinicians to continually remove the scope from the patient’s body to clean it during surgery. Kelling allows surgeons to maintain their visual field throughout the case thereby reducing frustration from interruptions. Surgeons can focus solely on the procedure and on the patient and utilize today’s high-resolution and advanced minimally invasive technologies as they are meant to.
Receiving FDA clearance in February of 2020, combined with rapid advances in manufacturing capability and an eager set of early customers, ClearCam was able to raise a highly sought-after seed round that quickly became oversubscribed.
